MOMETASONE FUROATE 0.1%w/w IP + FUSIDIC ACID 2.0%w/w IP

An effective topical therapy for inflamed skin conditions such as eczema, psoriasis and dermatitis in which infection may be a problem. Blocks the production of prostaglandins (chemical messengers) that make the affected area red, swollen and itchy. An effective drug against bacterial infections and reduces swelling, redness, and itchiness due to infections. Demonstrates greater anti‐inflammatory activity and a longer duration of action than betamethasone. (Fabrizio Spada, 2018) Clears various skin infections caused by certain kinds of bacteria by interfering with bacterial protein synthesis. (Bandyopadhyay, 2021) A potent drug that shows activity against a range of pathogens but has mainly been used to treat staphylococcal infection. (Benjamin P Howden, 2006) An effective bacteriostatic agent for treating several skin infections. (Mervt M Almostafa, 2022) A well-tolerated topical glucocorticoid drug for the management of patients with atopic dermatitis, seborrheic dermatitis, and psoriasis. (A Prakash, 1998) A valuable agent for the treatment of skin and soft tissue infections, particularly those due to Staphylococcus aureus. (Rita Pimenta, 2019) A good therapeutic choice for the treatment of impetigo and infected atopic dermatitis. (Benjamin P. Howden, 2006)